Related Experiment Video
Updated: Aug 2, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Increased mortality after coronary stenting in patients treated with clopidogrel without loading dose. Evidence from
G G L Biondi-Zoccai1, P Agostoni, L Testa
1Institute of Cardiology, Caholic University, Rome, Italy. gbiondizoccai@tiscali.it
Insights
Clopidogrel with a loading dose is as effective as ticlopidine after coronary stenting. However, clopidogrel without a loading dose significantly increases the risk of death or myocardial infarction.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Trials
Background:
- Clopidogrel is an alternative to ticlopidine post-coronary stenting, valued for hematologic safety.
- Debate exists regarding clopidogrel's efficacy compared to ticlopidine.
Purpose of the Study:
- To systematically review randomized trials comparing clopidogrel versus ticlopidine after coronary stenting.
- To evaluate the comparative efficacy and safety of clopidogrel and ticlopidine in patients undergoing coronary stenting.
Main Methods:
- Systematic review and meta-analysis of five randomized trials (2,962 patients).
- Searched multiple databases including Medline, BioMed Central, and Current Contents (1986-2003).
- Computed fixed-effect relative risks for mortality, with subgroup analyses based on clopidogrel loading dose regimens.
Main Results:
- Overall, a non-significant trend towards increased mortality with clopidogrel (2.3%) versus ticlopidine (1.7%) was observed.
- Clopidogrel with a loading dose showed non-significantly lower mortality (0.9%) compared to ticlopidine (1.6%).
- Clopidogrel without a loading dose was associated with a significantly higher risk of death (4.2%) compared to ticlopidine (1.7%).
Conclusions:
- Clopidogrel with a loading regimen appears equivalent or superior to ticlopidine post-coronary stenting.
- Clopidogrel therapy without a loading dose is linked to a significantly increased risk of death or myocardial infarction.
Aim:
Clopidogrel is an established alternative to ticlopidine in addition to aspirin after coronary stenting because of its hematologic safety, but its efficacy in comparison to ticlopidine is debated. We thus systematically reviewed randomized trials comparing clopidogrel vs ticlopidine after coronary stenting.
Methods:
Medline (1/1986-10/2003), BioMed Central, Central, Current Contents, LILACS and mRCT were searched. Fixed-effect relative risks (RR [95% CI]) were computed, and the primary end-point was death. Heterogeneity tests and subgroup analyses were performed according to loading vs non-loading clopidogrel scheme.
Results:
Five trials were retrieved (2 962 patients, average follow-up 7.4 months). In 3 studies both clopidogrel and ticlopidine were started with a loading dose, in 1 trial clopidogrel was administered without loading, and in 1 trial clopidogrel could be administered with or without loading. Overall analysis (p for heterogeneity=0.12) showed a non-significant trend toward increased mortality in patients treated with clopidogrel (38/1 649 [2.3%]) vs ticlopidine (22/1 313 [1.7%], RR=1.64 [0.94-2.86], p=0.080). After stratification, clopidogrel with loading was associated with non-significantly lower mortality rates than ticlopidine (9/959 [0.9%] vs 13/798 [1.6%], RR=0.68 [0.29-1.63], p=0.39). Instead, clopidogrel without any loading yielded a highly significantly 3-fold increased risk of death than ticlopidine (29/690 [4.2%] vs 9/515 [1.7%], RR=2.9 [1.45-6.1], p=0.0029). Similar results were obtained for the rate of death or non-fatal myocardial infarction.
Conclusion:
This meta-analysis suggests that clopidogrel treatment including a loading regimen is equivalent or may even be superior to ticlopidine after coronary stenting. However, current evidence shows conversely that clopidogrel therapy in the absence of a loading dose is associated with a significantly higher risk of death or myocardial infarction.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Peripheral Artery Disease III: Interprofessional Care